
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Patient-derived organoids as a model to study tubo-ovarian carcinoma: a pathologist’s perspective - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4AD4A8AF2ED8305AD4A003A9459DB.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jovares">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Ovarian Research">
<meta name="citation_title" content="Patient-derived organoids as a model to study tubo-ovarian carcinoma: a pathologist’s perspective">
<meta name="citation_author" content="Catarina Alves-Vale">
<meta name="citation_author_institution" content="Department of Pathology, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author_institution" content="Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal">
<meta name="citation_author_institution" content="Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal">
<meta name="citation_author_institution" content="Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author" content="Beatriz Galvão">
<meta name="citation_author_institution" content="Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal">
<meta name="citation_author" content="Ana Rita Silvestre">
<meta name="citation_author_institution" content="Department of Pathology, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author" content="José Silva Pereira">
<meta name="citation_author_institution" content="Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author" content="Li Bei">
<meta name="citation_author_institution" content="Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author" content="João Paulo Fernandes">
<meta name="citation_author_institution" content="Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author" content="Paula Borralho">
<meta name="citation_author_institution" content="Department of Pathology, CUF Oncologia, Lisboa, Portugal">
<meta name="citation_author_institution" content="Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal">
<meta name="citation_author" content="Maria Carmo-Fonseca">
<meta name="citation_author_institution" content="Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal">
<meta name="citation_author_institution" content="Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal">
<meta name="citation_author" content="Noélia Custódio">
<meta name="citation_author_institution" content="Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal">
<meta name="citation_author_institution" content="Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="18">
<meta name="citation_firstpage" content="191">
<meta name="citation_doi" content="10.1186/s13048-025-01766-4">
<meta name="citation_pmid" content="40835947">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/pdf/13048_2025_Article_1766.pdf">
<meta name="description" content="Tubo-ovarian carcinoma, a leading cause of gynaecological-related mortality, holds substantial biological and clinical heterogeneity. Despite advancements in drug development, predicting therapeutic efficacy remains challenging, partly due to the ...">
<meta name="og:title" content="Patient-derived organoids as a model to study tubo-ovarian carcinoma: a pathologist’s perspective">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Tubo-ovarian carcinoma, a leading cause of gynaecological-related mortality, holds substantial biological and clinical heterogeneity. Despite advancements in drug development, predicting therapeutic efficacy remains challenging, partly due to the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366147">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13048-025-01766-4"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13048_2025_Article_1766.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366147%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366147/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366147/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jovares.png" alt="Journal of Ovarian Research logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Ovarian Research" title="Link to Journal of Ovarian Research" shape="default" href="https://ovarianresearch.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Ovarian Res</button></div>. 2025 Aug 20;18:191. doi: <a href="https://doi.org/10.1186/s13048-025-01766-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13048-025-01766-4</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Ovarian%20Res%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Ovarian%20Res%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Ovarian%20Res%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Ovarian%20Res%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Patient-derived organoids as a model to study tubo-ovarian carcinoma: a pathologist’s perspective</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alves-Vale%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Catarina Alves-Vale</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Catarina Alves-Vale</span></h3>
<div class="p">
<sup>1</sup>Department of Pathology, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">
<sup>2</sup>Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal </div>
<div class="p">
<sup>3</sup>Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal </div>
<div class="p">
<sup>4</sup>Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alves-Vale%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Catarina Alves-Vale</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galv%C3%A3o%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Beatriz Galvão</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Beatriz Galvão</span></h3>
<div class="p">
<sup>2</sup>Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Galv%C3%A3o%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Beatriz Galvão</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Silvestre%20AR%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Ana Rita Silvestre</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Ana Rita Silvestre</span></h3>
<div class="p">
<sup>1</sup>Department of Pathology, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Silvestre%20AR%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana Rita Silvestre</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pereira%20JS%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">José Silva Pereira</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">José Silva Pereira</span></h3>
<div class="p">
<sup>4</sup>Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pereira%20JS%22%5BAuthor%5D" class="usa-link"><span class="name western">José Silva Pereira</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bei%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Li Bei</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Li Bei</span></h3>
<div class="p">
<sup>4</sup>Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bei%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Li Bei</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandes%20JP%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">João Paulo Fernandes</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">João Paulo Fernandes</span></h3>
<div class="p">
<sup>4</sup>Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandes%20JP%22%5BAuthor%5D" class="usa-link"><span class="name western">João Paulo Fernandes</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borralho%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Paula Borralho</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Paula Borralho</span></h3>
<div class="p">
<sup>1</sup>Department of Pathology, CUF Oncologia, Lisboa, Portugal </div>
<div class="p">
<sup>3</sup>Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borralho%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paula Borralho</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carmo-Fonseca%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Maria Carmo-Fonseca</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Maria Carmo-Fonseca</span></h3>
<div class="p">
<sup>2</sup>Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal </div>
<div class="p">
<sup>3</sup>Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carmo-Fonseca%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Carmo-Fonseca</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cust%C3%B3dio%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Noélia Custódio</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Noélia Custódio</span></h3>
<div class="p">
<sup>2</sup>Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal </div>
<div class="p">
<sup>3</sup>Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cust%C3%B3dio%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Noélia Custódio</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Pathology, CUF Oncologia, Lisboa, Portugal </div>
<div id="Aff2">
<sup>2</sup>Gulbenkian Institute for Molecular Medicine, Edifício Egas Moniz Avenida Professor Egas Moniz, Lisboa, 1649-028 Portugal </div>
<div id="Aff3">
<sup>3</sup>Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal </div>
<div id="Aff4">
<sup>4</sup>Gynaecological Oncology Unit, CUF Oncologia, Lisboa, Portugal </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 15; Accepted 2025 Jul 26; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366147  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40835947/" class="usa-link">40835947</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Tubo-ovarian carcinoma, a leading cause of gynaecological-related mortality, holds substantial biological and clinical heterogeneity. Despite advancements in drug development, predicting therapeutic efficacy remains challenging, partly due to the limited availability of in vitro models that accurately replicate tumour behaviour. We present a concise overview of the intrahospital workflow for establishing patient-derived organoids and analyse the morphological and immunophenotypical features of high-grade serous carcinoma (HGSC), serous borderline tumour (SBT)/low-grade serous carcinoma (LGSC), and normal fallopian tube (FT) organoids.</p></section><section id="sec2"><h3 class="pmc_sec_title">Results</h3>
<p id="Par2">Samples were collected from patients undergoing surgery or paracentesis. Tissue underwent mechanical and enzymatical digestion. Resulting cell suspensions were resuspended in an extracellular matrix substitute for subsequent culture. Despite the low efficacy in establishing HGSC organoids (<em>n</em> = 1/7, 14%; 96 days, 11 passages), we successfully established two organoid lines of SBT/LGSC (<em>n</em> = 2/2, 100%; 65 days, 7 passages; 134 days, 16 passages) and normal FT (<em>n</em> = 2/2, 100%; 73 days, 10 passages; 58 days, 8 passages). HGSC organoids exhibited limited growth and mostly irregular structures, while preserving the p53 immunostaining pattern of the original tumour. SBT/LGSC and FT organoids maintained features of architectural complexity and faithfully recapitulated the original immunoprofile.</p></section><section id="sec3"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par3">This study highlights the need for a multidisciplinary collaboration in both clinical and research settings to establish patient-derived organoids. It emphasises the pivotal contribution of pathologists in meticulous sampling and organoid characterisation. The integration of diverse expertise is essential for maximising the potential of organoids as preclinical tools, advancing our understanding of tubo-ovarian carcinoma, and ultimately improving patient outcomes.</p></section><section id="sec4"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13048-025-01766-4.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Patient-derived organoids, Tubo-ovarian carcinoma, Fallopian tube, Pre-clinical models</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par4">Tubo-ovarian carcinoma is the second leading cause of mortality among gynaecological malignancies, following cervical cancer [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. It encompasses five main types: high-grade serous carcinoma (HGSC), low-grade serous carcinoma (LGSC), endometrioid carcinoma, clear cell carcinoma and mucinous carcinoma [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. The paradigm has shifted from considering serous carcinoma as a singular type to recognising HGSC and LGSC as distinct entities, with contrasting morphological, immunophenotypical, molecular, and clinical features [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>–<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. HGSC, the most frequent histological type, is primarily thought to originate in the fallopian tube (FT) epithelium from the precursor serous tubal intraepithelial carcinoma (STIC) [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Given its insidious progression and aggressiveness, approximately 75% of patients are diagnosed at advanced stage, frequently accompanied by peritoneal involvement and ascites [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. In contrast, LGSC, a rare form of ovarian carcinoma, is postulated to arise through a stepwise progression from ovarian epithelial inclusions (with a possible tubal origin), transforming into serous cystadenoma, serous borderline tumour (SBT) and, ultimately, into LGSC [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. It affects predominantly younger women, follows a more indolent clinical course, but exhibits a poor prognosis in advanced stages, primarily due to its intrinsic relative chemoresistance [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. The distinct molecular mechanisms underlying LGSC pathogenesis require alternative therapeutic strategies, as platinum-based therapy, the standard for HGSC, often proves less effective for this subtype [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p>
<p id="Par5">Despite significant advances in targeted therapy and biomarker identification, predicting therapeutic sensitivity remains a challenge [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. One major limitation is the paucity of in vitro models capable of accurately simulating tumour behaviour. Moreover, understanding the early steps of tumorigenesis is vital for developing effective preventive strategies. Recognising this gap, the emergence of organoids – three-dimensional, self-renewing, and self-organising models, recapitulating the properties of the tissue of origin – offers a transformative approach for studying cancer [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Organoids can be initiated from pluripotent stem cells or organ-restricted adult stem cells, as in the case of patient-derived organoids [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. While these models have been established across various types of normal and neoplastic tissue, their implementation presents unique challenges compared to conventional cell culture techniques [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par6">In this paper, we present an analysis of the morphological and immunophenotypical properties of patient-derived organoids from HGSC, SBT/LGSC, and normal FT. Despite the small sample size, we aimed to bridge the gap between established pathology protocols in the clinical setting and organoid technology. We discuss key upstream factors that may affect the success of organoid derivation and the challenges encountered within our intrahospital workflow, underscoring the importance of a multidisciplinary collaboration to maximise organoid generation and ensure accurate characterisation of these human in vitro models.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<p id="Par7">Material and reagents references are listed in Supplementary Material.</p>
<section id="Sec3"><h3 class="pmc_sec_title">Sample collection</h3>
<p id="Par8">This study was approved by the Ethics Committee of CUF Descobertas Hospital, Lisbon, Portugal. Eligible patients were identified through the Gynaecological Tumour Board. Samples were collected from consenting patients immediately after surgery or paracentesis (Fig. <a href="#Fig1" class="usa-link">1</a>). After pathological assessment through frozen section, cancer tissue samples (5–10 mm-width) were promptly collected, avoiding areas of necrosis, haemorrhage, and hydropic degeneration. Tubal samples were obtained from macroscopically normal salpingectomy specimens of patients undergoing surgery for benign uterine pathology (2 mm-width fragments from the distal part of each tube, excluding fimbria). Samples were transported in cold DPBS and processed within 2–3 h. Ascitic fluid samples were evaluated through a Papanicolaou-stained smear, with a maximum storage time of 3 h at 4 °C before further processing.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366147_13048_2025_1766_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/12366147/cdf5bfe4b8ca/13048_2025_1766_Fig1_HTML.jpg" loading="lazy" id="d33e466" height="426" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathology-guided sample processing for organoid generation. Schematic representation elucidating the sample collection process for patient-derived organoid generation, including assessment of sample quality and histological diagnosis (comprising tissue samples and effusions, e.g. ascitic fluid). Note: Not drawn to scale. FFPE: Formalin-fixed, paraffin-embedded</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">Generation of tubo-ovarian carcinoma organoids</h3>
<p id="Par9">Tissue samples were diced into 2-mm fragments in basal medium (Advanced DMEM/F-12, 1x GlutaMax, 1% (v/v) HEPES and 1% (v/v) Penicillin-Streptomycin), containing Type II Collagenase (2.5 mg/mL), using sterilised scalpels and tweezers (Fig. <a href="#Fig2" class="usa-link">2</a>) [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. After incubation for 30–45 min at 37 °C with agitation, samples were filtered through a 70 μm strainer, and spun at 300xg for 10 min at 4 °C. When hematic, the resulting pellet was washed with ACK Lysing Buffer followed by washing in basal medium and pelleting as before. For effusions, the digestion steps were skipped. Cell counting was performed using a Neubauer chamber.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366147_13048_2025_1766_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/12366147/b262f1a84cf5/13048_2025_1766_Fig2_HTML.jpg" loading="lazy" id="d33e473" height="432" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Protocol overview for patient-derived organoid culture. Tissue is processed through mechanical and enzymatic steps, followed by filtration. Cells are resuspended in extracellular matrix substitute and plated in droplets, with culture medium. Organoid cultures are characterised by morphological and immunophenotypical analysis. Note: Not drawn to scale</p></figcaption></figure><p id="Par10">For culture, 45 µL-droplets of phenol red-free Matrigel<sup>®</sup> (basement membrane extract), each containing ~ 30 000–40 000 cells, were placed on a pre-warmed 6-well plate [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. The plate was left upside down in an incubator (37 °C for 20 min) for solidification of Matrigel<sup>®</sup>. 2 mL of tumour organoid complete medium were then added [Basal medium supplemented with 100 ng/mL Noggin, 100 ng/mL R-Spondin1, 1x B27, 1.25 mM N-Acetyl-L-Cysteine, 10 mM Nicotinamide, 5 µM A83-01, 100 ng/mL FGF-10, 100 ng/mL EGF, 10 ng/mL FGF-2, 1 µM Prostaglandin E2 and 10 µM SB 202190] [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. 10 µM ROCK inhibitor Y-27632 was added upon initial plating, but removed at first medium change. Medium was changed every 2–3 days.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Generation of normal fallopian tube organoids</h3>
<p id="Par11">FT samples were cut into 2-mm fragments in basal medium (same as for tumour), with 0.5 mg/mL DNase I, 2 mg/mL trypsin from bovine pancreas and 0.5 mg/mL Type II Collagenase (Fig. <a href="#Fig2" class="usa-link">2</a>). This mix was incubated for 45 min at 37 °C with agitation. The subsequent steps were as previously described for tumour organoids, with the following modifications on medium: addition of 25% (v/v) Wnt-3 A conditioned medium, change of R-Spondin1 concentration (500 ng/mL), and absence of FGF-2, Prostaglandin E2, and SB 202190 [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Organoids subculture</h3>
<p id="Par12">Organoids were passaged at suitable ratios (1:1–1:3, depending on confluency). After incubation with pre-warmed (37 °C) Accutase<sup>®</sup> solution, for up to 5 min at room temperature, organoids were mechanically sheared through a P1000 pipette tip, transferred to a Falcon<sup>®</sup> tube with basal medium for centrifugation (300xg for 10 min at 4 °C), resuspended in basal medium and mixed with Matrigel<sup>®</sup> for reseeding as above. Cultures were observed on a Zeiss Primovert bright-field inverted microscope (Zeiss AxioCam Erc5s camera) every 2–3 days.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Histological and immunohistochemical study</h3>
<p id="Par13">Medium was removed, wells were washed with 1x PBS and buffered formalin (10%) was added. Organoids were then transferred to a 15 mL tube with a Pasteur pipette and later resuspended in warm HistoGel™, solidified at 4 °C for 5–10 min, and then processed and paraffin-embedded. 3 μm sections on positively charged slides were stained with H&amp;E and, after ULTRA CC1 antigen retrieval, processed on Ventana BenchMark ULTRA automated staining platform with pre-diluted anti-PAX-8, anti-WT1, anti-p53, anti-ERα, anti-PR, and/or anti-Ki67. Antibodies were run using ultraView DAB detection kit (for anti-ERα and anti-PR) or OptiView DAB IHC Detection Kit (for the remaining antibodies). All slides included an external immunohistochemical tissue control to ensure staining accuracy.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Immunofluorescence of whole-mount organoids</h3>
<p id="Par14">Upon organoid passaging, 10 µL-Matrigel<sup>®</sup> droplets were plated in a µ-Slide 8 Well chambered coverslip and covered with complete medium. Once ready for fixation, medium was removed, the wells were rinsed with 1x PBS and organoids were fixed with gentle swirling with 4% (w/v) PFA in 1x PBS for 20 min, at room temperature. After washing with 1x PBS (3 × 10 min each), organoids were stored at 4 °C. For permeabilisation, organoids were incubated with 0.5% (w/v) Triton™ X-100 in 1x PBS for 20 min at room temperature with gentle agitation. Blocking was performed using 3% (w/v) BSA in 1x PBS, for 45 min at room temperature. Rabbit anti-Ki-67 (1/100) and mouse anti-EpCAM conjugated with FITC at 5 µg/mL (2.5/100), diluted in 1.5% (w/v) BSA in 1x PBS, were used as primary antibodies. After overnight incubation, in a humid chamber at 4 °C, each well was washed with 1x PBS containing 0.5% Tween<sup>®</sup> 20 (3 × 10 min each). The secondary antibodies used were horse anti-mouse IgG DyLight<sup>®</sup> 488 (1/200) and goat anti-rabbit IgG DyLight<sup>®</sup> 594 (1/200) diluted in 1.5% (w/v) BSA in 1x PBS. Organoids were incubated with 150 µL of the respective antibody, in the dark, for 1 h at room temperature. Subsequently, were rinsed twice and washed with 1x PBS containing 0.5% Tween<sup>®</sup> 20, followed by a 10 min incubation with 0.5 µg/mL DAPI in 1x PBS and washed in 1x PBS containing 0.5% Tween<sup>®</sup> 20 (3 × 5 min each). After the final wash, 100 µL of mounting medium made in-house [9.2 mM p-Phenylenediamine in 90% (w/v) sterile glycerol and 1x PBS, pH 9.5] was added to each well. Images were acquired on a Zeiss LSM 710 confocal point-scanning microscope (Plan-Apochromat 20x/0.8 M27 objective).</p></section></section><section id="Sec9"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec10"><h3 class="pmc_sec_title">Successful generation of patient-derived tubo-ovarian carcinoma and normal fallopian tube organoids</h3>
<p id="Par15">Tubo-ovarian carcinoma samples and normal (unmatched) fallopian tube (FT) tissue were obtained from consenting patients undergoing adnexal tumour resection and/or salpingo-oophorectomy for benign pathology, respectively. Additionally, ascitic fluid was collected from patients submitted to paracentesis for confirmed or suspected adnexal malignancy. Tumour and normal FT fresh tissue samples were collected after rapid pathological assessment (Fig. <a href="#Fig1" class="usa-link">1</a>). Tissue was then mechanically and enzymatically dissociated (Fig. <a href="#Fig2" class="usa-link">2</a>). Cell suspensions were filtered, followed by resuspension in an extracellular matrix substitute and plating with supplemented medium (Fig. <a href="#Fig2" class="usa-link">2</a>) [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. </p>
<p id="Par16">We considered that organoids were successfully established if they displayed stable growth for over four passages. Despite the low efficacy in establishing HGSC organoids (<em>n</em> = 1/7, 14%; 11 passages), we successfully established organoids from two SBT/LGSC – cultured for 65 days (7 passages) and 134 days (16 passages). We also generated normal FT organoids from two patients– expanded for 73 days (10 passages) and 58 days (8 passages). Table <a href="#Tab1" class="usa-link">1</a> provides clinical information and time in culture for each sample.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinicopathological features of each sample used for organoid derivation and respective culture duration</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Sample</th>
<th align="left" colspan="1" rowspan="1">Patient age (years)</th>
<th align="left" colspan="1" rowspan="1">Stage (FIGO)</th>
<th align="left" colspan="1" rowspan="1">Timing of sample collection</th>
<th align="left" colspan="1" rowspan="1">CT (response)</th>
<th align="left" colspan="1" rowspan="1">BRCA status</th>
<th align="left" colspan="1" rowspan="1">Type of sample</th>
<th align="left" colspan="1" rowspan="1">Days (Passages) in culture</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_1</td>
<td align="center" colspan="1" rowspan="1">53</td>
<td align="left" colspan="1" rowspan="1">IIIA1i</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">NACT (partial response– CRS2)</td>
<td align="left" colspan="1" rowspan="1">
<em>BRCA1</em> intron 16 rearrangement (S) (G - NA)</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">15 (P0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_2</td>
<td align="center" colspan="1" rowspan="1">80</td>
<td align="left" colspan="1" rowspan="1">IA</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">12 (P0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_3</td>
<td align="center" colspan="1" rowspan="1">49</td>
<td align="left" colspan="1" rowspan="1">IIB</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Neg (G + S)</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">96 (P11)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_4</td>
<td align="center" colspan="1" rowspan="1">49</td>
<td align="left" colspan="1" rowspan="1">IIIB</td>
<td align="left" colspan="1" rowspan="1">At relapse</td>
<td align="left" colspan="1" rowspan="1">Under CT</td>
<td align="left" colspan="1" rowspan="1">Neg (G + S)</td>
<td align="left" colspan="1" rowspan="1">Ascites</td>
<td align="left" colspan="1" rowspan="1">30 (P3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_5</td>
<td align="center" colspan="1" rowspan="1">71</td>
<td align="left" colspan="1" rowspan="1">IIIB</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">NACT (partial response– CRS2)</td>
<td align="left" colspan="1" rowspan="1">
<em>BRCA1</em> c.4084G &gt; A p.(Asp1362Asn) (S) (G – Neg)</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">7 (P0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_6</td>
<td align="center" colspan="1" rowspan="1">49</td>
<td align="left" colspan="1" rowspan="1">IIC</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">
<em>BRCA1</em> c.1969 C &gt; T p.(GIn657*) (G + S)</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">14 (P0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HGSC_7</td>
<td align="center" colspan="1" rowspan="1">86</td>
<td align="left" colspan="1" rowspan="1">IVA</td>
<td align="left" colspan="1" rowspan="1">At diagnostic paracentesis</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Ascites</td>
<td align="left" colspan="1" rowspan="1">20 (P1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SBT/LGSC_1</td>
<td align="center" colspan="1" rowspan="1">37</td>
<td align="left" colspan="1" rowspan="1">IIIA2</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Neg (NA)</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">65 (P7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LGSC_2</td>
<td align="center" colspan="1" rowspan="1">39</td>
<td align="left" colspan="1" rowspan="1">IIIB</td>
<td align="left" colspan="1" rowspan="1">At primary surgery</td>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">Neg (G + S)</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">134 (P16)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FT_1</td>
<td align="center" colspan="1" rowspan="1">48</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Surgery for benign uterine pathology</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">73 (P10)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FT_2</td>
<td align="center" colspan="1" rowspan="1">85</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Surgery for benign uterine pathology</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Surgical</td>
<td align="left" colspan="1" rowspan="1">58 (P8)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p22"><p>Characterisation of the fallopian tube (FT), serous borderline tumour (SBT)/low-grade serous carcinoma (LGSC) and high-grade serous carcinoma (HGSC) samples, regarding patient age, tumour staging, timing of sample collection, concomitant/prior history of chemotherapy (and response, if applicable), <em>BRCA</em> gene mutational status, type of sample and number of days and respective passage before culture discontinuation. Only HGSC cultures were discontinued by having reached a steady-state. FIGO - International Federation of Gynecology and Obstetrics; NA - Not applicable/ available; CRS– Chemotherapy Response Score; CT– chemotherapy; G– Germline mutation; S– Somatic mutation</p></div></div></section></section><section id="Sec11"><h3 class="pmc_sec_title">High-grade serous carcinoma organoids exhibited limited grow in culture</h3>
<p id="Par18">Samples of HGSC obtained from seven patients, including two ascitic fluids, were processed for culture. Two patients had been submitted to neoadjuvant chemotherapy, and one patient was under chemotherapy at the time of sampling (Table <a href="#Tab1" class="usa-link">1</a>). HGSC culture establishment efficacy was lower (<em>n</em> = 1/7, 14%) than for SBT/LGSC and FT (100%) (Table <a href="#Tab1" class="usa-link">1</a>), presenting less cellularity and a slower cell culture growth rate. Long-term culture was only possible for one sample (HGSC_3) (96 days, 11 passages). Notably, organoids derived from <em>BRCA1</em>-mutated tumours tended to exhibit a more limited growth, prompting early culture discontinuation – HGSC_1, HGSC_5 and HGSC_6 (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<p id="Par19">HGSC cultures presented mostly irregular discohesive aggregates and, at a lesser degree, regular and organised structures, either cystic or trabecular, sometimes mirroring exactly the original tumour architecture (Fig. <a href="#Fig3" class="usa-link">3</a>A, B). Organoids showed marked cytological atypia and frequent apoptotic bodies, which were also observed in the corresponding parental samples (Fig. <a href="#Fig3" class="usa-link">3</a>C, D).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366147_13048_2025_1766_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/12366147/a59bf5e87578/13048_2025_1766_Fig3_HTML.jpg" loading="lazy" id="d33e798" height="412" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>High-grade serous carcinoma (HGSC) organoids exhibited limited growth in culture, but retained p53 expression pattern. A– Representative bright-field images of HGSC organoids (HGSC_3, P11 D11), showing regular spherical structures alongside irregular, discohesive aggregates (zoom in, left). Scale bar: 500 μm. B– Bright-field images of HGSC organoids (HGSC_3, P10 D6) on the left, mimicking the trabecular architecture observed in the primary tumour (right), with peripheral palisading. Scale bar: 100 μm. C– Frequent apoptotic bodies were observed in culture (left), in concordance to the original tumour (right). Scale bar: 100 μm. D– Organoids maintained moderate to marked cytological atypia, while retaining the expression of CK7 and PAX8. WT1 expression was lost in HGSC_3, but retained in HGSC_7 organoids (note: histiocytes, which are WT1-, are also identified in the ascitic fluid). The “mutant-type” pattern of p53 expression is concordant between the original neoplasm and the respective organoids - overexpression pattern in HGSC_3 (expression in &gt;80% of cells), and null pattern in HGSC_7 (absence of staining, with appropriate external controls). Scale bar: 100 μm</p></figcaption></figure><p id="Par20">Immunohistochemical analysis revealed diffuse positivity for CK7 (cytokeratin 7), a low molecular weight cytokeratin expressed in a variety of epithelial tissues, including tubo-ovarian neoplasms, and for PAX8 (paired box 8), a marker of Müllerian lineage, in both the original tissue and the corresponding organoid lines [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. In contrast, expression of WT1 (Wilms Tumour 1), a characteristic marker of serous neoplasms, was lost in HGSC_3 organoids (Fig. <a href="#Fig3" class="usa-link">3</a>D) [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Notably, a heterogeneous pattern of staining was observed in the corresponding primary tumour (Fig. <a href="#Fig3" class="usa-link">3</a>D). Moreover, over 95% of HGSC cases are described to exhibit <em>TP53</em> mutations, and the type of mutation strongly correlates with the staining pattern [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Indeed, the analysed organoids showed a “mutant-type” p53 expression pattern, either null or of overexpression, in concordance with the original neoplasm (Fig. <a href="#Fig3" class="usa-link">3</a>D) [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. However, the low cellularity of these cultures precluded further characterisation.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Long-term organoids derived from serous borderline tumour/low-grade serous carcinoma reflected the architectural complexity and the immunoprofile of the corresponding neoplasms</h3>
<p id="Par22">We successfully generated organoids from two cases of LGSC (Table <a href="#Tab1" class="usa-link">1</a>). Of significance, in one case (SBT/LGSC1), the histological examination of the fragment juxtaposed to that utilised for culture (referred to as ‘mirror’ fragment) exhibited SBT morphology, despite a definitive diagnosis of LGSC following extensive analysis of the surgical specimen, highlighting tumour heterogeneity.</p>
<p id="Par23">SBT/LGSC organoids exhibited distinct stages of maturation, predominantly with a spherical morphology (Fig. <a href="#Fig4" class="usa-link">4</a>A) and occasional cribriform and/or micropapillary architecture, demonstrating their ability to preserve complex features in culture (Figs. <a href="#Fig4" class="usa-link">4</a>B and <a href="#Fig6" class="usa-link">6</a>A). Organoids were composed of cubic to columnar cells, primarily oriented towards the lumen, with minimal nuclear pleomorphism (Fig. <a href="#Fig4" class="usa-link">4</a>B, C).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366147_13048_2025_1766_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/12366147/7f9533a70982/13048_2025_1766_Fig4_HTML.jpg" loading="lazy" id="d33e869" height="481" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Architectural and immunophenotypical fidelity of serous borderline tumour/low-grade serous carcinoma (SBT/LGSC) organoids. A– Representative bright-field image of early culture (LGSC_2, P0 D7), exhibiting predominantly hollow structures with diverse shapes. Scale bar: 500 μm. B– Bright-field images revealed cribriform (right, * indicating multiple lumens) and micropapillary (left, arrowheads indicating projections) patterns in SBT/LGSC organoids (SBT/LGSC_1, P2 D6), with corresponding histology (SBT/LGSC_1, P7). Scale bar: 100 μm. C– Immunohistochemical study illustrating overall tissue-organoids concordance: CK7 was focal in SBT/LGSC_1 tissue, with absence of staining in organoids, but LGSC_2 tissue and organoids showed a strong and diffuse positivity; PAX8 was also diffusely positive, despite a variable WT1; p53 immunostaining exhibited a wild-type pattern; SBT/LGSC_1 organoids (P2) displayed focal weak positivity for estrogen receptors (ER) and absence of staining for progesterone receptors (PR), while LGSC_2 (P5) accurately mirrored the original tumour. Scale bar: 100 μm</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366147_13048_2025_1766_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/12366147/017f0813f261/13048_2025_1766_Fig6_HTML.jpg" loading="lazy" id="d33e941" height="368" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immunofluorescence of whole-mount patient-derived low-grade serous carcinoma (LGSC) and normal fallopian tube (FT) organoids. A, B  –  Organoids were stained for the epithelial marker EpCAM (green) and nuclear marker DAPI (blue), revealing differences in morphology. LGSC organoids (A) formed denser and more complex structures harbouring multiple lumens, contrasting to the hollow FT organoids (B), with focal invaginations. C– Representative images of organoids stained for the proliferation marker Ki-67 (red) and nuclear marker DAPI (blue) indicating a high proliferative rate in both organoid types. Scale bar: 50 μm</p></figcaption></figure><p id="Par24">Immunohistochemistry analysis revealed concordance between the organoids and the parental tumours (Fig. <a href="#Fig4" class="usa-link">4</a>C). Both showed positivity for the Müllerian marker PAX8, although inconsistently for CK7 and WT1 (Fig. <a href="#Fig4" class="usa-link">4</a>C) [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Furthermore, p53 expression in a wild-type pattern aligns with the characteristic absence of <em>TP53</em> mutations in LGSC (Fig. <a href="#Fig4" class="usa-link">4</a>C) [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Considering the potential use of hormonotherapy in LGSC, we performed immunohistochemistry for estrogen receptors (ER) and progesterone receptors (PR) [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. Notable heterogeneity in expression was observed within the tissue of both tumours (Fig. <a href="#Fig4" class="usa-link">4</a>C). In organoids, SBT/LGSC_1 showed a reduction in ER expression with loss of PR expression, while LGSC_2 organoids maintained consistent expression for both receptor types (Fig. <a href="#Fig4" class="usa-link">4</a>C).</p></section><section id="Sec13"><h3 class="pmc_sec_title">Fallopian tube organoids recapitulated mucosal architecture and immunophenotype</h3>
<p id="Par27">We have successfully cultivated organoids from normal FT epithelium of two patients (Table <a href="#Tab1" class="usa-link">1</a>). Organoids were predominantly spherical (Figs. <a href="#Fig5" class="usa-link">5</a>A and <a href="#Fig6" class="usa-link">6</a>B) and composed of a monolayered epithelium with polarised cubic to columnar cells (Fig. <a href="#Fig5" class="usa-link">5</a>B). However, the development of epithelium folds, a feature of architecture complexity, mirroring normal tubal mucosa, was observed in several organoids during culture, and later confirmed by histological analysis (Fig. <a href="#Fig5" class="usa-link">5</a>A, B). The presence of both secretory and ciliated cells was morphologically evident, with secretory cells being the prevailing cell type (Fig. <a href="#Fig5" class="usa-link">5</a>B, C). FT organoids showed expression of PAX8, a Müllerian marker specifically expressed by the tubal secretory cells, but not in the ciliated population (Fig. <a href="#Fig5" class="usa-link">5</a>C) [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Organoids were also diffusely positive for CK7, a marker for the secretory cells, highlighting the predominance of this cell type in culture (Fig. <a href="#Fig5" class="usa-link">5</a>C) [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>].</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366147_13048_2025_1766_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76ac/12366147/63d5935e30a5/13048_2025_1766_Fig5_HTML.jpg" loading="lazy" id="d33e931" height="450" width="669" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Fallopian tube (FT) organoids captured essential architectural features and the immunophenotype of normal human FT. A– Bright-field image of early FT organoid culture (FT_2, P1 D7), displaying spherical structures (left). Occasional intraluminal projections resembling the development of mucosal plicae were noticed (FT_1, P10, D12) (right).  Scale bar: 500 μm (left), 100 μm (right). B– Histological analysis confirmed the presence of plicae-like epithelial projections (left; FT_1, P2). However, organoids were mainly composed of a simple monolayered, polarised epithelium, featuring secretory and ciliated cells (arrowhead) (right; FT_1, P3). Scale bar: 100 μm. C– FT organoids expressed CK7 and the lineage marker PAX8, with focal staining for WT1. CK7 and PAX8 highlight secretory cells, while ciliated cells are PAX8-negative. Despite a high p53 positivity, a wild-type pattern is maintained, accompanied by an elevated proliferative index (Ki-67). Scale bar: 100 μm</p></figcaption></figure><p id="Par28">In contrast, organoid immunoreactivity for WT1, a lineage marker also expressed in the normal FT epithelium, was only focal (Fig. <a href="#Fig5" class="usa-link">5</a>C). As anticipated for a normal tissue, organoids displayed high, but wild-type expression pattern for p53 (Fig. <a href="#Fig5" class="usa-link">5</a>C). Recognising its function as a checkpoint regulator induced during cell division, we conducted a Ki-67 analysis. Notably, FT organoids were more proliferative than the original tissue (75–90% versus &lt; 5%, respectively) (Fig. <a href="#Fig5" class="usa-link">5</a>C), potentially leading to increased p53 expression. Histological examination of FT specimens revealed no evidence of neoplasm. Both FT and LGSC organoids displayed a high proportion of Ki-67 + cells (Fig. <a href="#Fig6" class="usa-link">6</a>C), compatible with the high proliferating rates observed in culture.</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par31">Tubo-ovarian carcinoma remains a major oncological challenge, with limited improvement on overall survival over the years [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. In this context, patient-derived cancer organoids have emerged as a promising in vitro model for precision oncology with potential for identification of relevant biomarkers and enabling high-throughput drug screening [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Several studies have reported the generation of patient-derived organoids from various types of tubo-ovarian carcinoma, as well as normal tissues comprising both tubal and ovarian surface epithelium [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>–<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>].</p>
<p id="Par32">HGSC accounts for the majority of cases and is characterised by high genomic instability, ubiquitous presence of <em>TP53</em> mutations and, less frequently, mutations in <em>BRCA1/2</em> genes, increasing its susceptibility to cellular stress, potentially impairing cell survival and adaptability to ex vivo culture conditions [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Successful establishment of organoid cultures has been reported from both chemotherapy-naïve and previously treated HGSC samples. Theoretically, prior exposure to chemotherapy may negatively affect culture establishment, as cytotoxic treatment can induce cellular senescence in a subset of tumour cells [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. For example, Maenhoudt et al. observed a slightly higher, although non-statistically significant, organoid derivation success rate in chemotherapy-naïve samples compared to those from previously treated patients (56% vs. 36%) [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. In contrast, Hill et al. reported comparable establishment rates between the two groups, provided that macroscopically visible tumour was present at debulking surgery [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. However, the success rate was lower in cases exhibiting an “extreme response” to chemotherapy, which we interpret as a Chemotherapy Response Score (CRS) of 3 [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Furthermore, their findings suggested that the percentage of viable tumour cells was an additional determinant of successful organoid culture [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. However, studies in other cancer types have not demonstrated an association between organoid derivation efficiency and tumour cell viability or necrosis, underscoring the multifactorial and context-dependent nature of culture success [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>, <a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. In our HGSC cohort (<em>n</em> = 7), organoid cultures were derived using specimens from patients aged 49–86 years, encompassing FIGO stages IA–IVA, and included both primary surgical specimens and ascitic fluid (Table <a href="#Tab1" class="usa-link">1</a>). Despite initiating cultures from all seven cases, only three (HGSC_3, HGSC_4, HGSC_7) could be propagated beyond passage 0, with only one maintained for 11 passages over a 96-day period. HGSC_1 and HGSC_5 originated from patients with a CRS2 (Table <a href="#Tab1" class="usa-link">1</a>), characterised by an “appreciable tumor response amidst viable tumor, both readily identifiable and tumor regularly distributed”. Of note, our samples were obtained from adnexal masses rather than the omentum, the latter being the standard site for CRS assessment [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Reported success rates in establishing long-term HGSC organoid cultures range from 23 to 83%, with the latest publications yielding the most favourable outcomes [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>, <a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>–<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Interestingly, although some authors have reported that Wnt-3 A and R-Spondin1 may limit HGSC organoid growth, the highest efficiency was achieved using a culture medium containing these factors, as originally formulated for FT organoids [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>–<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Additionally, supplementation with β-estradiol has shown to improve HGSC organoid generation, despite not having been used by Hill et al. [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. In summary, considering that only one of our HGSC samples yielded a long-term culture, the extent to which our findings can be extrapolated is inherently limited. Further validation in larger, independent cohorts is required to validate and expand these observations.</p>
<p id="Par33">Given the frequently advanced stage of HGSC at diagnosis, it is mandatory to understand the molecular mechanisms underlying malignant transformation, in order to find effective screening and prophylactic strategies. Most cases of HGSC are considered to originate in the tubal fimbria from a precursor lesion - serous tubal intraepithelial carcinoma (STIC) [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Critical insights into its pathogenesis have predominantly relied on formalin-fixed, paraffin-embedded samples or commercial cell lines, notwithstanding the inherent limitations of these models [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>–<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. Patient-derived FT epithelium organoids may constitute a suitable complement for this end [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>].</p>
<p id="Par34">We successfully achieved long-term cultures of FT and SBT/LGSC organoids, which captured the architectural complexity and immunoprofile of the original tissue, thus supporting the reliability of this model (Figs. <a href="#Fig4" class="usa-link">4</a>, <a href="#Fig5" class="usa-link">5</a> and <a href="#Fig6" class="usa-link">6</a>). Acknowledging that immunohistochemistry offers a very restricted evaluation of gene expression profile, the absence of detailed molecular characterisation constitutes a limitation of this study. An intriguing observation was the partial or complete loss of WT1 immunostaining in some organoids (Figs. <a href="#Fig3" class="usa-link">3</a>D, <a href="#Fig4" class="usa-link">4</a>C and <a href="#Fig5" class="usa-link">5</a>C). This may result from intratumoral heterogeneity – demonstrated, for example, by the variable expression of WT1 in HGSC_3, and also CK7 in SBT/LGSC_1 (Figs. <a href="#Fig3" class="usa-link">3</a>D and <a href="#Fig4" class="usa-link">4</a>C) – coupled with selection pressure within the culture, induced by media composition, thus favouring specific tumour subpopulations. Indeed, WT1 is a transcription factor pivotal in organogenesis and has been described to stabilise both p53 and β-catenin proteins [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>–<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. This interaction led us to hypothesise that WT1 levels might be modulated by the Wnt/β-catenin pathway, through R-Spondin1 and/or Wnt-3 A included in the medium [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>, <a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. However, existing evidence suggests that β-catenin safeguards WT1 from degradation, rather than the opposite [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. While we acknowledge that these mechanisms remain hypothetical without direct experimental validation, they provide a possible framework for understanding WT1 expression changes in our organoid models.</p>
<p id="Par35">Establishing high-quality, disease-specific biobank collections is essential for advancing organoid-based research, yet it remains challenging [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. The timely collection and processing of fresh tissue samples involves inherent logistical complexity, necessitating close collaboration among surgical teams, oncologists, pathologists, and scientists.</p>
<p id="Par36">Various factors associated with sample collection can profoundly impact the viability of organoids and downstream applications. Identification of eligible patients in advance is a critical first step for both effective sample collection and subsequent processing, especially in the setting of a multi-institutional project. Informed consent from all patients should be obtained prior to sample collection. Study specimens may be collected not only during scheduled procedures such as surgeries, but also during urgent clinical episodes (e.g. effusion drainage), underscoring the necessity for effective team-wide communication to maximise the number of eligible samples. The time between tissue excision or effusion drainage and processing must be minimised, as prolonged ischemia induces hypoxic stress, alters gene expression, and compromises cellular viability [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Notably, organoids derived from post-mortem samples have also been described [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. Given that sample collection for organoid derivation is integrated in the standard clinical care, the sampling process must be carefully incorporated into the institutional workflows for routine pathological examination. Accordingly, fresh material can be collected either in the operating room or in the pathology department. Even though antibiotics are often added to culture media, this process should be performed within a laminar flow cabinet using sterilised material.</p>
<p id="Par37">When obtaining tissue samples for cancer organoid derivation, a careful sampling approach is essential to prevent contamination from normal tissue. Conversely, if the aim is to establish organoids from normal tissue, similar diligence is required to exclude any tumour cells. Also, an initial morphological assessment (e.g., cellularity, necrosis and fibrosis degree), especially after neoadjuvant chemotherapy, can help guide sample selection and subsequent processing, highlighting the pivotal role of pathologists in this procedure (Fig. <a href="#Fig1" class="usa-link">1</a>). Both frozen section and rapid on-site cytological evaluation (ROSE) using Diff-Quik or Papanicolaou staining can be used. Cytological samples, either effusions or those obtained through fine-needle aspiration, also proved suitable for organoid derivation, offering an alternative when solid tissue samples are unavailable [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>, <a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Effusion samples contain varying proportions of tumour cells, reactive mesothelial cells, lymphocytes, and macrophages. A ROSE evaluation can help assess tumour cell proportion and determine sample suitability for organoid culture. However, enrichment strategies, such as fluorescence-activated cell sorting (FACS), can be used in both effusions and tissue samples after dissociation to select the cells of interest for further culture [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Interestingly, co-culture techniques with stromal cells, such as fibroblasts, endothelial cells or immune cells, have been applied to organoid technology, increasing its complexity [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>].</p>
<p id="Par38">A multi-sampling approach is recommended to account for intratumoral cell heterogeneity, while a longitudinal sampling from the same patient over time (when applicable) can provide insights into tumour evolution and treatment resistance mechanisms [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>, <a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>, <a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Notably, tubo-ovarian tumours, frequently resected at large sizes, usually offer broader sampling scopes compared to smaller-sized malignancies. In contrast, normal FT sampling should be more cautious. The College of American Pathologists advocates for the total inclusion of the specimen following the Sectioning and Extensively Examining the FIMbriated End (SEE-FIM) protocol in cases of risk-reducing salpingectomies for patients with <em>BRCA</em> germline mutations or suspected hereditary risk [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Recent European consensus recommendations support using SEE-FIM for any salpingectomy specimen [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. However, an international panel of expert gynaecopathologists did not reach an agreement based on the low percentage of incidental STIC in the general population and ongoing debate about its clinical impact. Nonetheless, full embedding of the fimbriated portion was recommended [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Therefore, when FT tissue is collected for research, adjacent “mirror” fragments should be collected and processed separately for histopathological analysis. Additional serial sectioning can improve STIC detection [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. Proper annotation of the anatomical regions from which FT fragments are collected (isthmus, ampulla, infundibulum or fimbriae) is important, considering differences in cellular populations [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>, <a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>].</p>
<p id="Par39">Comprehensive and comparative molecular and functional analyses, including genomic and transcriptomic profiling, as well as drug response assays, should complement the histopathological evaluation to ensure the fidelity and translational relevance of patient-derived organoids [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>].</p></section><section id="Sec15"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par40">Despite the limited number of successfully generated patient-derived organoids, this study contributed to the evolving landscape of organoid models. The number of organoids established from HGSC, SBT/LGSC and FT remains below the ideal number for broader generalizability. This underscores the need for expanding our biobank with more cases, including treatment-naïve and post-treatment carcinoma specimens, to validate and extend these findings. Furthermore, this study underscored the need for a multidisciplinary collaboration in both clinical and research settings to establish these models as robust preclinical tools, allowing to expand our understanding of disease biology, supporting clinical decision-making, and, ultimately, improving cancer-related outcomes.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12366147/bin/13048_2025_1766_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (156KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We are grateful for the support from the Bioimaging Unit at Gulbenkian Institute for Molecular Medicine in whole-mount immunofluorescence execution. Figures 1 and 2 were created using BioRender.com.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ACK</dt>
<dd><p id="Par44">Ammonium-chloride-potassium</p></dd>
<dt>BSA</dt>
<dd><p id="Par45">Bovine serum albumin</p></dd>
<dt>CK7</dt>
<dd><p id="Par46">Cytokeratin 7</p></dd>
<dt>DAB</dt>
<dd><p id="Par47">Diaminobenzidine</p></dd>
<dt>DAPI</dt>
<dd><p id="Par48">4′,6-diamidino-2-phenylindole</p></dd>
<dt>DMEM</dt>
<dd><p id="Par49">Dulbecco’s Modified Eagle Medium</p></dd>
<dt>DPBS</dt>
<dd><p id="Par50">Dulbecco’s phosphate-buffered saline</p></dd>
<dt>EGF</dt>
<dd><p id="Par51">Epidermal growth factor</p></dd>
<dt>ER</dt>
<dd><p id="Par52">Estrogen receptor</p></dd>
<dt>FGF</dt>
<dd><p id="Par53">Fibroblast growth factor</p></dd>
<dt>FITC</dt>
<dd><p id="Par54">Fluorescein isothiocyanate</p></dd>
<dt>FT</dt>
<dd><p id="Par55">Fallopian tube</p></dd>
<dt>H&amp;E</dt>
<dd><p id="Par56">Hematoxylin and eosin</p></dd>
<dt>HGSC</dt>
<dd><p id="Par57">High-grade serous carcinoma</p></dd>
<dt>IHC</dt>
<dd><p id="Par58">Immunohistochemistry</p></dd>
<dt>LGSC</dt>
<dd><p id="Par59">Low-grade serous carcinoma</p></dd>
<dt>PAX8</dt>
<dd><p id="Par60">Paired box gene 8</p></dd>
<dt>PBS</dt>
<dd><p id="Par61">Phosphate-buffered saline</p></dd>
<dt>PR</dt>
<dd><p id="Par62">Progesterone receptor</p></dd>
<dt>ROCK</dt>
<dd><p id="Par63">Rho-associated protein kinase</p></dd>
<dt>SBT</dt>
<dd><p id="Par64">Serous borderline tumour</p></dd>
<dt>STIC</dt>
<dd><p id="Par65">Serous tubal intraepithelial carcinoma</p></dd>
<dt>WT1</dt>
<dd><p id="Par66">Wilms tumour 1</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>C. A-V and B.G wrote the original draft. B.G, C. A-V and N.C performed cell culture experiments. A.R.S executed histological and immunohistochemical processing, interpreted by C.A-V and P.B. B.G and N.C performed whole-mount immunofluorescence assays. C.A-V, J.S.P, L.B and J.P.F identified eligible patients and provided patient samples. C. A-V, J.S.P, J.P.F and L.B collected clinical data. N.C and M.C-F supervised the study. All authors reviewed and approved the final version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This study was funded by “16.ª Bolsa de Investigação Fundação AstraZeneca/Faculdade de Medicina da Universidade de Lisboa”, Fundação para a Ciência e a Tecnologia, Portugal (PTDC/MED-ONC/3921/2021) and Programa Gilead GÉNESE 2022 (Grant ID Number: 17799). C.A-V reports research funding from CUF as part of a doctoral scholarship grant.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par41">This study was conducted in strict accordance with ethical guidelines. Approval was obtained from the Ethics Committee of CUF Descobertas Hospital, Lisbon, Portugal, under the reference “OVARY” (CE– 026/20– JMS/is). Informed consent was obtained from all participants involved in the study.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par42">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par43">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Catarina Alves-Vale and Beatriz Galvão contributed equally to this work.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
</cite> [<a href="https://doi.org/10.3322/caac.21834" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38572751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bray%20F,%20Laversanne%20M,%20Sung%20H,%20Ferlay%20J,%20Siegel%20RL,%20Soerjomataram%20I,%20et%20al.%20Global%20cancer%20statistics%202022:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J%20Clin.%202024;74:229%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393:1240–53.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)32552-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30910306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lheureux%20S,%20Gourley%20C,%20Vergote%20I,%20Oza%20AM.%20Epithelial%20ovarian%20cancer.%20Lancet.%202019;393:1240%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Cheung AN, Ellenson LH, Gilks CB, Kim K-R, Kong CS, Lax SF, et al. Tumours of the ovary. editor. WHO classification of tumours - Female genital tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2020. WHO Classification of Tumours Editorial Board.</cite> [<a href="https://scholar.google.com/scholar_lookup?Cheung%20AN,%20Ellenson%20LH,%20Gilks%20CB,%20Kim%20K-R,%20Kong%20CS,%20Lax%20SF,%20et%20al.%20Tumours%20of%20the%20ovary.%20editor.%20WHO%20classification%20of%20tumours%20-%20Female%20genital%20tumours.%205th%20ed.%20Lyon:%20International%20Agency%20for%20Research%20on%20Cancer;%202020.%20WHO%20Classification%20of%20Tumours%20Editorial%20Board." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Prat J, D’Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular. Hum Pathol. 2018;80:11–27.
</cite> [<a href="https://doi.org/10.1016/j.humpath.2018.06.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29944973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Prat%20J,%20D%E2%80%99Angelo%20E,%20Espinosa%20I.%20Ovarian%20carcinomas:%20at%20least%20five%20different%20diseases%20with%20distinct%20histological%20features%20and%20molecular.%20Hum%20Pathol.%202018;80:11%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kurman RJ, Shih IM. The dualistic model of ovarian carcinogenesis revisited, revised, and expanded. Am J Pathol. 2016;186(4):733–47.
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2015.11.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5808151/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27012190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurman%20RJ,%20Shih%20IM.%20The%20dualistic%20model%20of%20ovarian%20carcinogenesis%20revisited,%20revised,%20and%20expanded.%20Am%20J%20Pathol.%202016;186(4):733%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Colombo N, Sessa C, Bois A, Ledermann J, Mccluggage WG, Mcneish I, et al. ESMO – ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer. 2019;30(5):672–705.</cite> [<a href="https://doi.org/10.1136/ijgc-2019-000308" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31048403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Colombo%20N,%20Sessa%20C,%20Bois%20A,%20Ledermann%20J,%20Mccluggage%20WG,%20Mcneish%20I,%20et%20al.%20ESMO%20%E2%80%93%20ESGO%20consensus%20conference%20recommendations%20on%20ovarian%20cancer:%20pathology%20and%20molecular%20biology,%20early%20and%20advanced%20stages,%20borderline%20tumours%20and%20recurrent%20disease.%20Int%20J%20Gynecol%20Cancer.%202019;30(5):672%E2%80%93705." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, et al. Grading ovarian serous carcinoma using a Two-Tier system. Am J Surg Pathol. 2004;28(4):496–504.
</cite> [<a href="https://doi.org/10.1097/00000478-200404000-00009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15087669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Malpica%20A,%20Deavers%20MT,%20Lu%20K,%20Bodurka%20DC,%20Atkinson%20EN,%20Gershenson%20DM,%20et%20al.%20Grading%20ovarian%20serous%20carcinoma%20using%20a%20Two-Tier%20system.%20Am%20J%20Surg%20Pathol.%202004;28(4):496%E2%80%93504." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Kuhn E, Kurman RJ, Vang R, Sehdev AS, Han G, Soslow R, et al. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions. J Pathol. 2012;226(3):421–6.
</cite> [<a href="https://doi.org/10.1002/path.3023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4782784/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuhn%20E,%20Kurman%20RJ,%20Vang%20R,%20Sehdev%20AS,%20Han%20G,%20Soslow%20R,%20et%20al.%20TP53%20mutations%20in%20serous%20tubal%20intraepithelial%20carcinoma%20and%20concurrent%20pelvic%20high-grade%20serous%20carcinoma-evidence%20supporting%20the%20clonal%20relationship%20of%20the%20two%20lesions.%20J%20Pathol.%202012;226(3):421%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Ducie J, Dao F, Considine M, Olvera N, Shaw PA, Kurman RJ, et al. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma. Nat Commun. 2017;8(1):1–9.
</cite> [<a href="https://doi.org/10.1038/s41467-017-01217-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5645359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29042553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ducie%20J,%20Dao%20F,%20Considine%20M,%20Olvera%20N,%20Shaw%20PA,%20Kurman%20RJ,%20et%20al.%20Molecular%20analysis%20of%20high-grade%20serous%20ovarian%20carcinoma%20with%20and%20without%20associated%20serous%20tubal%20intra-epithelial%20carcinoma.%20Nat%20Commun.%202017;8(1):1%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19(1):3–9.
</cite> [<a href="https://doi.org/10.1097/GCO.0b013e328011a21f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17218844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crum%20CP,%20Drapkin%20R,%20Miron%20A,%20Ince%20TA,%20Muto%20M,%20Kindelberger%20DW,%20et%20al.%20The%20distal%20fallopian%20tube:%20a%20new%20model%20for%20pelvic%20serous%20carcinogenesis.%20Curr%20Opin%20Obstet%20Gynecol.%202007;19(1):3%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Kurman RJ, Shih IM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - Shifting the paradigm. Hum Pathol. 2011;42(7):918–31.
</cite> [<a href="https://doi.org/10.1016/j.humpath.2011.03.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3148026/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21683865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurman%20RJ,%20Shih%20IM.%20Molecular%20pathogenesis%20and%20extraovarian%20origin%20of%20epithelial%20ovarian%20cancer%20-%20Shifting%20the%20paradigm.%20Hum%20Pathol.%202011;42(7):918%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol. 2013;24(Suppl):16–21.</cite> [<a href="https://doi.org/10.1093/annonc/mdt463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24265397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurman%20RJ.%20Origin%20and%20molecular%20pathogenesis%20of%20ovarian%20high-grade%20serous%20carcinoma.%20Ann%20Oncol.%202013;24(Suppl):16%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13(4):255–61.
</cite> [<a href="https://doi.org/10.1038/nrclinonc.2015.224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26787282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Narod%20S.%20Can%20advanced-stage%20ovarian%20cancer%20be%20cured?%20Nat%20Rev%20Clin%20Oncol.%202016;13(4):255%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, et al. Tubal origin of ovarian low-grade serous carcinoma. Mod Pathol. 2011;24(11):1488–99.
</cite> [<a href="https://doi.org/10.1038/modpathol.2011.106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21701538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20J,%20Abushahin%20N,%20Pang%20S,%20Xiang%20L,%20Chambers%20SK,%20Fadare%20O,%20et%20al.%20Tubal%20origin%20of%20ovarian%20low-grade%20serous%20carcinoma.%20Mod%20Pathol.%202011;24(11):1488%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ahn G, Folkins AK, McKenney JK, Longacre TA. Low-grade serous carcinoma of the ovary: clinicopathologic analysis of 52 invasive cases and identification of a possible noninvasive intermediate lesion. Am J Surg Pathol. 2016;40(9):1165–76.
</cite> [<a href="https://doi.org/10.1097/PAS.0000000000000693" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27487741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahn%20G,%20Folkins%20AK,%20McKenney%20JK,%20Longacre%20TA.%20Low-grade%20serous%20carcinoma%20of%20the%20ovary:%20clinicopathologic%20analysis%20of%2052%20invasive%20cases%20and%20identification%20of%20a%20possible%20noninvasive%20intermediate%20lesion.%20Am%20J%20Surg%20Pathol.%202016;40(9):1165%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Grisham RN, Slomovitz BM, Andrews N, Banerjee S, Brown J, Carey MS, et al. Low-grade serous ovarian cancer: expert consensus report on the state of the science. Int J Gynecol Cancer. 2023;33(9):1331–44.
</cite> [<a href="https://doi.org/10.1136/ijgc-2023-004610" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10511962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37591609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grisham%20RN,%20Slomovitz%20BM,%20Andrews%20N,%20Banerjee%20S,%20Brown%20J,%20Carey%20MS,%20et%20al.%20Low-grade%20serous%20ovarian%20cancer:%20expert%20consensus%20report%20on%20the%20state%20of%20the%20science.%20Int%20J%20Gynecol%20Cancer.%202023;33(9):1331%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Miller RE, Leary A, Scott CL, Serra V, Lord CJ, Bowtell D, et al. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer. Ann Oncol. 2020;31(12):1606–22.
</cite> [<a href="https://doi.org/10.1016/j.annonc.2020.08.2102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33004253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miller%20RE,%20Leary%20A,%20Scott%20CL,%20Serra%20V,%20Lord%20CJ,%20Bowtell%20D,%20et%20al.%20ESMO%20recommendations%20on%20predictive%20biomarker%20testing%20for%20homologous%20recombination%20deficiency%20and%20PARP%20inhibitor%20benefit%20in%20ovarian%20cancer.%20Ann%20Oncol.%202020;31(12):1606%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Funingana IG, Reinius MAV, Petrillo A, Ang JE, Brenton JD. Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer? Semin Cancer Biol. 2021;77:67–82.
</cite> [<a href="https://doi.org/10.1016/j.semcancer.2021.02.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33607245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Funingana%20IG,%20Reinius%20MAV,%20Petrillo%20A,%20Ang%20JE,%20Brenton%20JD.%20Can%20integrative%20biomarker%20approaches%20improve%20prediction%20of%20platinum%20and%20PARP%20inhibitor%20response%20in%20ovarian%20cancer?%20Semin%20Cancer%20Biol.%202021;77:67%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Clevers H. Modeling development and disease with organoids. Cell. 2016;165(7):1586–97.
</cite> [<a href="https://doi.org/10.1016/j.cell.2016.05.082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27315476/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clevers%20H.%20Modeling%20development%20and%20disease%20with%20organoids.%20Cell.%202016;165(7):1586%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407–18.
</cite> [<a href="https://doi.org/10.1038/s41568-018-0007-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29692415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Drost%20J,%20Clevers%20H.%20Organoids%20in%20cancer%20research.%20Nat%20Rev%20Cancer.%202018;18(7):407%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Tong L, Cui W, Zhang B, Fonseca P, Zhao Q, Zhang P, et al. Patient-derived organoids in precision cancer medicine. Med. 2024;5(11):1351–77.
</cite> [<a href="https://doi.org/10.1016/j.medj.2024.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39341206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tong%20L,%20Cui%20W,%20Zhang%20B,%20Fonseca%20P,%20Zhao%20Q,%20Zhang%20P,%20et%20al.%20Patient-derived%20organoids%20in%20precision%20cancer%20medicine.%20Med.%202024;5(11):1351%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Thorel L, Perréard M, Florent R, Divoux J, Coffy S, Vincent A, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med. 2024;56(7):1531–51.
</cite> [<a href="https://doi.org/10.1038/s12276-024-01272-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11297165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38945959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thorel%20L,%20Perr%C3%A9ard%20M,%20Florent%20R,%20Divoux%20J,%20Coffy%20S,%20Vincent%20A,%20et%20al.%20Patient-derived%20tumor%20organoids:%20a%20new%20avenue%20for%20preclinical%20research%20and%20precision%20medicine%20in%20oncology.%20Exp%20Mol%20Med.%202024;56(7):1531%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Hill SJ, Decker B, Roberts EA, Horowitz NS, Muto MG Jr. Prediction of DNA repair inhibitor response in Short-Term Patient-Derived ovarian cancer organoids. Cancer Discov. 2018;8(11):1404–21.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-18-0474" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6365285/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30213835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hill%20SJ,%20Decker%20B,%20Roberts%20EA,%20Horowitz%20NS,%20Muto%20MG%20Jr.%20Prediction%20of%20DNA%20repair%20inhibitor%20response%20in%20Short-Term%20Patient-Derived%20ovarian%20cancer%20organoids.%20Cancer%20Discov.%202018;8(11):1404%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Benton G, Arnaoutova I, George J, Kleinman HK, Koblinski J. Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev. 2014;79–80:3–18.
</cite> [<a href="https://doi.org/10.1016/j.addr.2014.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24997339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Benton%20G,%20Arnaoutova%20I,%20George%20J,%20Kleinman%20HK,%20Koblinski%20J.%20Matrigel:%20from%20discovery%20and%20ECM%20mimicry%20to%20assays%20and%20models%20for%20cancer%20research.%20Adv%20Drug%20Deliv%20Rev.%202014;79%E2%80%9380:3%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34(5):627–35.
</cite> [<a href="https://doi.org/10.1097/PAS.0b013e3181da7687" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20414098/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Laury%20AR,%20Hornick%20JL,%20Perets%20R,%20Krane%20JF,%20Corson%20J,%20Drapkin%20R,%20et%20al.%20PAX8%20reliably%20distinguishes%20ovarian%20serous%20tumors%20from%20malignant%20mesothelioma.%20Am%20J%20Surg%20Pathol.%202010;34(5):627%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, et al. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: A comprehensive immunohistochemical study. Mod Pathol. 2011;24(6):751–64.
</cite> [<a href="https://doi.org/10.1038/modpathol.2011.3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21317881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ozcan%20A,%20Shen%20SS,%20Hamilton%20C,%20Anjana%20K,%20Coffey%20D,%20Krishnan%20B,%20et%20al.%20PAX%208%20expression%20in%20non-neoplastic%20tissues,%20primary%20tumors,%20and%20metastatic%20tumors:%20A%20comprehensive%20immunohistochemical%20study.%20Mod%20Pathol.%202011;24(6):751%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Seidman JD, Ronnett BM, Shih I-M, Cho KR, Kurman RJ. Epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s pathology of the female genital tract. 7th ed. Springer; 2019. pp. 841–966.</cite>
</li>
<li id="CR28">
<span class="label">28.</span><cite>Tornos C, Soslow R, Chen S, Akram M, Hummer AJ, Abu-Rustum N, et al. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary. Am J Surg Pathol. 2005;29(11):1482–9.
</cite> [<a href="https://doi.org/10.1097/01.pas.0000176429.88702.36" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16224215/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tornos%20C,%20Soslow%20R,%20Chen%20S,%20Akram%20M,%20Hummer%20AJ,%20Abu-Rustum%20N,%20et%20al.%20Expression%20of%20WT1,%20CA%20125,%20and%20GCDFP-15%20as%20useful%20markers%20in%20the%20differential%20diagnosis%20of%20primary%20ovarian%20carcinomas%20versus%20metastatic%20breast%20cancer%20to%20the%20ovary.%20Am%20J%20Surg%20Pathol.%202005;29(11):1482%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IM, Kurman RJ. Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: A rereview of cases lacking TP53 mutations in the cancer genome atlas ovarian study. Int J Gynecol Pathol. 2016;35(1):48–55.
</cite> [<a href="https://doi.org/10.1097/PGP.0000000000000207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4696053/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26166714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vang%20R,%20Levine%20DA,%20Soslow%20RA,%20Zaloudek%20C,%20Shih%20IM,%20Kurman%20RJ.%20Molecular%20alterations%20of%20TP53%20are%20a%20defining%20feature%20of%20ovarian%20high-grade%20serous%20carcinoma:%20A%20rereview%20of%20cases%20lacking%20TP53%20mutations%20in%20the%20cancer%20genome%20atlas%20ovarian%20study.%20Int%20J%20Gynecol%20Pathol.%202016;35(1):48%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>The Cancer Genome Atlas Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609–15.
</cite> [<a href="https://doi.org/10.1038/nature10166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3163504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21720365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?The%20Cancer%20Genome%20Atlas%20Network.%20Integrated%20genomic%20analyses%20of%20ovarian%20carcinoma.%20Nature.%202011;474(7353):609%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Köbel M, Ronnett BM, Singh N, Soslow RA, Gilks CB, McCluggage WG. Interpretation of P53 immunohistochemistry in endometrial carcinomas: toward increased reproducibility. Int J Gynecol Pathol. 2019;38(Suppl 1):123–31.</cite> [<a href="https://doi.org/10.1097/PGP.0000000000000488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6127005/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29517499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?K%C3%B6bel%20M,%20Ronnett%20BM,%20Singh%20N,%20Soslow%20RA,%20Gilks%20CB,%20McCluggage%20WG.%20Interpretation%20of%20P53%20immunohistochemistry%20in%20endometrial%20carcinomas:%20toward%20increased%20reproducibility.%20Int%20J%20Gynecol%20Pathol.%202019;38(Suppl%201):123%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Köbel M, Piskorz AM, Lee S, Lui S, Lepage C, Marass F, et al. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res. 2016;2:247–58.
</cite> [<a href="https://doi.org/10.1002/cjp2.53" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5091634/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27840695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?K%C3%B6bel%20M,%20Piskorz%20AM,%20Lee%20S,%20Lui%20S,%20Lepage%20C,%20Marass%20F,%20et%20al.%20Optimized%20p53%20immunohistochemistry%20is%20an%20accurate%20predictor%20of%20TP53%20mutation%20in%20ovarian%20carcinoma.%20J%20Pathol%20Clin%20Res.%202016;2:247%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: A mutational analysis with immunohistochemical correlation. Am J Surg Pathol. 2005;29(2):218–24.
</cite> [<a href="https://doi.org/10.1097/01.pas.0000146025.91953.8d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15644779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singer%20G,%20St%C3%B6hr%20R,%20Cope%20L,%20Dehari%20R,%20Hartmann%20A,%20Cao%20DF,%20et%20al.%20Patterns%20of%20p53%20mutations%20separate%20ovarian%20serous%20borderline%20tumors%20and%20low-%20and%20high-grade%20carcinomas%20and%20provide%20support%20for%20a%20new%20model%20of%20ovarian%20carcinogenesis:%20A%20mutational%20analysis%20with%20immunohistochemical%20correlation.%20Am%20J%20Surg%20Pathol.%202005;29(2):218%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, et al. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007;104(2):331–7.
</cite> [<a href="https://doi.org/10.1016/j.ygyno.2006.08.052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17064757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bowen%20NJ,%20Logani%20S,%20Dickerson%20EB,%20Kapa%20LB,%20Akhtar%20M,%20Benigno%20BB,%20et%20al.%20Emerging%20roles%20for%20PAX8%20in%20ovarian%20cancer%20and%20endosalpingeal%20development.%20Gynecol%20Oncol.%202007;104(2):331%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, et al. Transformation of the fallopian tube secretory epithelium leads to High-Grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell. 2013;24(6):751–65.
</cite> [<a href="https://doi.org/10.1016/j.ccr.2013.10.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3917315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24332043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perets%20R,%20Wyant%20GA,%20Muto%20KW,%20Bijron%20JG,%20Poole%20BB,%20Chin%20KT,%20et%20al.%20Transformation%20of%20the%20fallopian%20tube%20secretory%20epithelium%20leads%20to%20High-Grade%20serous%20ovarian%20cancer%20in%20Brca;Tp53;Pten%20models.%20Cancer%20Cell.%202013;24(6):751%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Hu Z, Artibani M, Alsaadi A, Wietek N, Morotti M, Shi T, et al. The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. Cancer Cell. 2020;37(2):226–e2427.
</cite> [<a href="https://doi.org/10.1016/j.ccell.2020.01.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32049047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20Z,%20Artibani%20M,%20Alsaadi%20A,%20Wietek%20N,%20Morotti%20M,%20Shi%20T,%20et%20al.%20The%20repertoire%20of%20serous%20ovarian%20cancer%20non-genetic%20heterogeneity%20revealed%20by%20single-cell%20sequencing%20of%20normal%20fallopian%20tube%20epithelial%20cells.%20Cancer%20Cell.%202020;37(2):226%E2%80%93e2427." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat Protoc. 2020;15(10):1–30.
</cite> [<a href="https://doi.org/10.1038/s41596-020-0379-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32929210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Driehuis%20E,%20Kretzschmar%20K,%20Clevers%20H.%20Establishment%20of%20patient-derived%20cancer%20organoids%20for%20drug-screening%20applications.%20Nat%20Protoc.%202020;15(10):1%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Kessler M, Hoffmann K, Brinkmann V, Thieck O, Jackisch S, Toelle B, et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat Commun. 2015;6:8989.
</cite> [<a href="https://doi.org/10.1038/ncomms9989" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4686873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26643275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kessler%20M,%20Hoffmann%20K,%20Brinkmann%20V,%20Thieck%20O,%20Jackisch%20S,%20Toelle%20B,%20et%20al.%20The%20Notch%20and%20Wnt%20pathways%20regulate%20stemness%20and%20differentiation%20in%20human%20fallopian%20tube%20organoids.%20Nat%20Commun.%202015;6:8989." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Del Valle JS, Husetic A, Diek D, Rutgers LF, Asseler JD, Metzemaekers J et al. Human ovarian surface epithelium organoids as a platform to study tissue regeneration. JoVE [Internet]. 2024(210):e66797.</cite> [<a href="https://doi.org/10.3791/66797" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39221930/" class="usa-link">PubMed</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Nero C, Vizzielli G, Lorusso D, Cesari E, Daniele G, Loverro M, et al. Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine. J Cancer Res Clin Oncol. 2024;150(3):146.
</cite> [<a href="https://doi.org/10.1186/s13046-021-01917-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8011220/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33789687/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nero%20C,%20Vizzielli%20G,%20Lorusso%20D,%20Cesari%20E,%20Daniele%20G,%20Loverro%20M,%20et%20al.%20Patient-derived%20organoids%20and%20high%20grade%20serous%20ovarian%20cancer:%20from%20disease%20modeling%20to%20personalized%20medicine.%20J%20Cancer%20Res%20Clin%20Oncol.%202024;150(3):146." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Hu H, Sun C, Chen J, Li Z. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment. J Cancer Res Clin Oncol. 2024;150(3):146.
</cite> [<a href="https://doi.org/10.1007/s00432-024-05654-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10955023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38509422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20H,%20Sun%20C,%20Chen%20J,%20Li%20Z.%20Organoids%20in%20ovarian%20cancer:%20a%20platform%20for%20disease%20modeling,%20precision%20medicine,%20and%20drug%20assessment.%20J%20Cancer%20Res%20Clin%20Oncol.%202024;150(3):146." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Ahmed AA, Etemadmoghadam D, Temple J, Lynch AG, Riad M, Sharma R, et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol. 2010;221(1):49–56.
</cite> [<a href="https://doi.org/10.1002/path.2696" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3262968/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20229506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmed%20AA,%20Etemadmoghadam%20D,%20Temple%20J,%20Lynch%20AG,%20Riad%20M,%20Sharma%20R,%20et%20al.%20Driver%20mutations%20in%20TP53%20are%20ubiquitous%20in%20high%20grade%20serous%20carcinoma%20of%20the%20ovary.%20J%20Pathol.%202010;221(1):49%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Uruski P, Sepetowska A, Konieczna C, Pakuła M, Wyrwa M, Tussupkaliyev A et al. Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and Paclitaxel in vitro. Cell Mol Biol Lett. 2021;26(1).</cite> [<a href="https://doi.org/10.1186/s11658-021-00287-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8532320/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34674640/" class="usa-link">PubMed</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Maenhoudt N, Defraye C, Boretto M, Jan Z, Heremans R, Boeckx B, et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Rep. 2020;14(4):717–29.</cite> [<a href="https://doi.org/10.1016/j.stemcr.2020.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7160357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32243841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maenhoudt%20N,%20Defraye%20C,%20Boretto%20M,%20Jan%20Z,%20Heremans%20R,%20Boeckx%20B,%20et%20al.%20Developing%20organoids%20from%20ovarian%20cancer%20as%20experimental%20and%20preclinical%20models.%20Stem%20Cell%20Rep.%202020;14(4):717%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Barbara A, Crothers, Krishnamurti UG, Birdsong GG, Klepeis V, Movahedi-Lankarani S, Otis CN. Protocol for the examination of specimens from patients with primary tumors of the ovary, fallopian tube, or peritoneum [Internet]. 2023 [cited 2024 Jan 2]. Available from: <a href="https://documents.cap.org/protocols/Ovary_FT_Perit_1.3.0.1.REL_CAPCP.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://documents.cap.org/protocols/Ovary_FT_Perit_1.3.0.1.REL_CAPCP.pdf</a></cite>
</li>
<li id="CR46">
<span class="label">46.</span><cite>Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández-Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic Gastrointestinal cancers. Science. 2018;359(6378):920–6.
</cite> [<a href="https://doi.org/10.1126/science.aao2774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6112415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29472484/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vlachogiannis%20G,%20Hedayat%20S,%20Vatsiou%20A,%20Jamin%20Y,%20Fern%C3%A1ndez-Mateos%20J,%20Khan%20K,%20et%20al.%20Patient-derived%20organoids%20model%20treatment%20response%20of%20metastatic%20Gastrointestinal%20cancers.%20Science.%202018;359(6378):920%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Nuciforo S, Fofana I, Matter MS, Blumer T, Calabrese D, Boldanova T, et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 2018;24(5):1363–76.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2018.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6088153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30067989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nuciforo%20S,%20Fofana%20I,%20Matter%20MS,%20Blumer%20T,%20Calabrese%20D,%20Boldanova%20T,%20et%20al.%20Organoid%20models%20of%20human%20liver%20cancers%20derived%20from%20tumor%20needle%20biopsies.%20Cell%20Rep.%202018;24(5):1363%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Hoffmann K, Berger H, Kulbe H, Thillainadarasan S, Mollenkopf H, Zemojtel T, et al. Stable expansion of high-grade serous ovarian cancer organoids requires a low‐Wnt environment. EMBO J. 2020;39(6):e104013.
</cite> [<a href="https://doi.org/10.15252/embj.2019104013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7073464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32009247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hoffmann%20K,%20Berger%20H,%20Kulbe%20H,%20Thillainadarasan%20S,%20Mollenkopf%20H,%20Zemojtel%20T,%20et%20al.%20Stable%20expansion%20of%20high-grade%20serous%20ovarian%20cancer%20organoids%20requires%20a%20low%E2%80%90Wnt%20environment.%20EMBO%20J.%202020;39(6):e104013." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Kopper O, Witte CJ, De, Lõhmussaar K, Valle-inclan JE, Hami N, Kester L, et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat Med. 2019;25:838–9.
</cite> [<a href="https://doi.org/10.1038/s41591-019-0422-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31011202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kopper%20O,%20Witte%20CJ,%20De,%20L%C3%B5hmussaar%20K,%20Valle-inclan%20JE,%20Hami%20N,%20Kester%20L,%20et%20al.%20An%20organoid%20platform%20for%20ovarian%20cancer%20captures%20intra-%20and%20interpatient%20heterogeneity.%20Nat%20Med.%202019;25:838%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Vias M, Gavarró LM, Sauer CM, Sanders DA, Piskorz AM, Couturier DL, et al. High-grade serous ovarian carcinoma organoids as models of chromosomal instability. Elife. 2023;12:e83867.
</cite> [<a href="https://doi.org/10.7554/eLife.83867" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10174694/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37166279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vias%20M,%20Gavarr%C3%B3%20LM,%20Sauer%20CM,%20Sanders%20DA,%20Piskorz%20AM,%20Couturier%20DL,%20et%20al.%20High-grade%20serous%20ovarian%20carcinoma%20organoids%20as%20models%20of%20chromosomal%20instability.%20Elife.%202023;12:e83867." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Senkowski W, Gall-Mas L, Falco MM, Li Y, Lavikka K, Kriegbaum MC, et al. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. Dev Cell. 2023;58(12):1106–21.
</cite> [<a href="https://doi.org/10.1016/j.devcel.2023.04.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10281085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37148882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Senkowski%20W,%20Gall-Mas%20L,%20Falco%20MM,%20Li%20Y,%20Lavikka%20K,%20Kriegbaum%20MC,%20et%20al.%20A%20platform%20for%20efficient%20establishment%20and%20drug-response%20profiling%20of%20high-grade%20serous%20ovarian%20cancer%20organoids.%20Dev%20Cell.%202023;58(12):1106%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Haile S, Corbett RD, Bilobram S, Bye MH, Kirk H, Pandoh P, et al. Sources of erroneous sequences and artifact chimeric reads in next generation sequencing of genomic DNA from formalin-fixed paraffin-embedded samples. Nucleic Acids Res. 2019;47(2):e12.
</cite> [<a href="https://doi.org/10.1093/nar/gky1142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6344851/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30418619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haile%20S,%20Corbett%20RD,%20Bilobram%20S,%20Bye%20MH,%20Kirk%20H,%20Pandoh%20P,%20et%20al.%20Sources%20of%20erroneous%20sequences%20and%20artifact%20chimeric%20reads%20in%20next%20generation%20sequencing%20of%20genomic%20DNA%20from%20formalin-fixed%20paraffin-embedded%20samples.%20Nucleic%20Acids%20Res.%202019;47(2):e12." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Fusenig NE, Capes-Davis A, Bianchini F, Sundell S, Lichter P. The need for a worldwide consensus for cell line authentication: experience implementing a mandatory requirement at the international journal of cancer. PLoS Biol. 2017;15(4):e2001438.
</cite> [<a href="https://doi.org/10.1371/journal.pbio.2001438" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5393552/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28414712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fusenig%20NE,%20Capes-Davis%20A,%20Bianchini%20F,%20Sundell%20S,%20Lichter%20P.%20The%20need%20for%20a%20worldwide%20consensus%20for%20cell%20line%20authentication:%20experience%20implementing%20a%20mandatory%20requirement%20at%20the%20international%20journal%20of%20cancer.%20PLoS%20Biol.%202017;15(4):e2001438." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Mei J, Tian H, Huang HS, Hsu CF, Liou Y, Wu N, et al. Cellular models of development of ovarian high-grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis. Cell Prolif. 2021;54(5):e13029.
</cite> [<a href="https://doi.org/10.1111/cpr.13029" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8088460/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33768671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mei%20J,%20Tian%20H,%20Huang%20HS,%20Hsu%20CF,%20Liou%20Y,%20Wu%20N,%20et%20al.%20Cellular%20models%20of%20development%20of%20ovarian%20high-grade%20serous%20carcinoma:%20A%20review%20of%20cell%20of%20origin%20and%20mechanisms%20of%20carcinogenesis.%20Cell%20Prolif.%202021;54(5):e13029." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Wagstaff M, Tsaponina O, Caalim G, Greenfield H, Milton-Harris L, Mancini EJ, et al. Crosstalk between b-catenin and WT1 signaling activity in acute myeloid leukemia. Haematologica. 2023;108(1):283–9.
</cite> [<a href="https://doi.org/10.3324/haematol.2021.280294" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9827145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35443562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wagstaff%20M,%20Tsaponina%20O,%20Caalim%20G,%20Greenfield%20H,%20Milton-Harris%20L,%20Mancini%20EJ,%20et%20al.%20Crosstalk%20between%20b-catenin%20and%20WT1%20signaling%20activity%20in%20acute%20myeloid%20leukemia.%20Haematologica.%202023;108(1):283%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 1995;9(17):2143–56.
</cite> [<a href="https://doi.org/10.1101/gad.9.17.2143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7657166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maheswaran%20S,%20Englert%20C,%20Bennett%20P,%20Heinrich%20G,%20Haber%20DA.%20The%20WT1%20gene%20product%20stabilizes%20p53%20and%20inhibits%20p53-mediated%20apoptosis.%20Genes%20Dev.%201995;9(17):2143%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Scholz H, Kirschner KM. Oxygen-Dependent gene expression in development and cancer: lessons learned from the wilms’ tumor gene, WT1. Front Mol Neurosci. 2011;4:4.
</cite> [<a href="https://doi.org/10.3389/fnmol.2011.00004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3047294/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21430823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scholz%20H,%20Kirschner%20KM.%20Oxygen-Dependent%20gene%20expression%20in%20development%20and%20cancer:%20lessons%20learned%20from%20the%20wilms%E2%80%99%20tumor%20gene,%20WT1.%20Front%20Mol%20Neurosci.%202011;4:4." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Nusse R, Clevers H. Wnt/β-Catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169(6):985–99.
</cite> [<a href="https://doi.org/10.1016/j.cell.2017.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28575679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nusse%20R,%20Clevers%20H.%20Wnt/%CE%B2-Catenin%20signaling,%20disease,%20and%20emerging%20therapeutic%20modalities.%20Cell.%202017;169(6):985%E2%80%9399." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Annaratone L, De Palma G, Bonizzi G, Sapino A, Botti G, Berrino E, et al. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch. 2021;479(2):233–46.
</cite> [<a href="https://doi.org/10.1007/s00428-021-03151-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8275637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34255145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Annaratone%20L,%20De%20Palma%20G,%20Bonizzi%20G,%20Sapino%20A,%20Botti%20G,%20Berrino%20E,%20et%20al.%20Basic%20principles%20of%20biobanking:%20from%20biological%20samples%20to%20precision%20medicine%20for%20patients.%20Virchows%20Arch.%202021;479(2):233%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Graham O, Rodriguez J, Abbott R, Lomonosova E, Fashemi B, Drexler R, et al. A toolkit for a modern gynecologic oncology tissue bank. Gynecol Oncol. 2024;189:1–8.
</cite> [<a href="https://doi.org/10.1016/j.ygyno.2024.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12052217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38971004/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Graham%20O,%20Rodriguez%20J,%20Abbott%20R,%20Lomonosova%20E,%20Fashemi%20B,%20Drexler%20R,%20et%20al.%20A%20toolkit%20for%20a%20modern%20gynecologic%20oncology%20tissue%20bank.%20Gynecol%20Oncol.%202024;189:1%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>von der Heyde S, Raman N, Gabelia N, Matias-Guiu X, Yoshino T, Tsukada Y, et al. Tumor specimen cold ischemia time impacts molecular cancer drug target discovery. Cell Death Dis. 2024;15(9):691.
</cite> [<a href="https://doi.org/10.1038/s41419-024-07090-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11427669/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39327466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?von%20der%20Heyde%20S,%20Raman%20N,%20Gabelia%20N,%20Matias-Guiu%20X,%20Yoshino%20T,%20Tsukada%20Y,%20et%20al.%20Tumor%20specimen%20cold%20ischemia%20time%20impacts%20molecular%20cancer%20drug%20target%20discovery.%20Cell%20Death%20Dis.%202024;15(9):691." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Pisapia DJ, Salvatore S, Pauli C, Hissong E, Eng K, Prandi D, et al. Next-Generation rapid autopsies enable tumor evolution tracking and generation of preclinical models. JCO Precis Oncol. 2017;14(1):100944.</cite> [<a href="https://doi.org/10.1200/PO.16.00038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5761727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29333526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pisapia%20DJ,%20Salvatore%20S,%20Pauli%20C,%20Hissong%20E,%20Eng%20K,%20Prandi%20D,%20et%20al.%20Next-Generation%20rapid%20autopsies%20enable%20tumor%20evolution%20tracking%20and%20generation%20of%20preclinical%20models.%20JCO%20Precis%20Oncol.%202017;14(1):100944." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Phifer CJ, Bergdorf KN, Bechard ME, Vilgelm A, Baregamian N, McDonald OG, et al. Obtaining patient-derived cancer organoid cultures via fine-needle aspiration. STAR Protoc. 2021;2(1):100220.
</cite> [<a href="https://doi.org/10.1016/j.xpro.2020.100220" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7758553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33377121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Phifer%20CJ,%20Bergdorf%20KN,%20Bechard%20ME,%20Vilgelm%20A,%20Baregamian%20N,%20McDonald%20OG,%20et%20al.%20Obtaining%20patient-derived%20cancer%20organoid%20cultures%20via%20fine-needle%20aspiration.%20STAR%20Protoc.%202021;2(1):100220." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Gerli MFM, Calà G, Beesley MA, Sina B, Tullie L, Sun KY, et al. Single-cell guided prenatal derivation of primary fetal epithelial organoids from human amniotic and tracheal fluids. Nat Med. 2024;30(3):875–87.
</cite> [<a href="https://doi.org/10.1038/s41591-024-02807-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10957479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38438734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gerli%20MFM,%20Cal%C3%A0%20G,%20Beesley%20MA,%20Sina%20B,%20Tullie%20L,%20Sun%20KY,%20et%20al.%20Single-cell%20guided%20prenatal%20derivation%20of%20primary%20fetal%20epithelial%20organoids%20from%20human%20amniotic%20and%20tracheal%20fluids.%20Nat%20Med.%202024;30(3):875%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Yuan J, Li X, Yu S. Cancer organoid co-culture model system: novel approach to guide precision medicine. Front Immunol. 2022;13:1061388.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.1061388" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9877297/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36713421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan%20J,%20Li%20X,%20Yu%20S.%20Cancer%20organoid%20co-culture%20model%20system:%20novel%20approach%20to%20guide%20precision%20medicine.%20Front%20Immunol.%202022;13:1061388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C et al. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024;35(3):248–66.</cite> [<a href="https://doi.org/10.1016/j.annonc.2023.11.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38307807/" class="usa-link">PubMed</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Mahe E, Tang S, Deb P, Sur M, Lytwyn A, Daya D. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the sectioning and extensively examining the fimbriated end (SEE-FIM) protocol? Int J Gynecol Pathol. 2013;32(4):353–7.
</cite> [<a href="https://doi.org/10.1097/PGP.0b013e318264ae09" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23722507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahe%20E,%20Tang%20S,%20Deb%20P,%20Sur%20M,%20Lytwyn%20A,%20Daya%20D.%20Do%20deeper%20sections%20increase%20the%20frequency%20of%20detection%20of%20serous%20tubal%20intraepithelial%20carcinoma%20(STIC)%20in%20the%20sectioning%20and%20extensively%20examining%20the%20fimbriated%20end%20(SEE-FIM)%20protocol?%20Int%20J%20Gynecol%20Pathol.%202013;32(4):353%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, et al. Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: A site for injury and serous cancer initiation. Stem Cells. 2012;30(11):2487–97.
</cite> [<a href="https://doi.org/10.1002/stem.1207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4442093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22911892/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paik%20DY,%20Janzen%20DM,%20Schafenacker%20AM,%20Velasco%20VS,%20Shung%20MS,%20Cheng%20D,%20et%20al.%20Stem-like%20epithelial%20cells%20are%20concentrated%20in%20the%20distal%20end%20of%20the%20fallopian%20tube:%20A%20site%20for%20injury%20and%20serous%20cancer%20initiation.%20Stem%20Cells.%202012;30(11):2487%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Dinh HQ, Lin X, Abbasi F, Nameki R, Haro M, Olingy CE, et al. Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube. Cell Rep. 2021;35(2):108978.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2021.108978" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10108902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33852846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dinh%20HQ,%20Lin%20X,%20Abbasi%20F,%20Nameki%20R,%20Haro%20M,%20Olingy%20CE,%20et%20al.%20Single-cell%20transcriptomics%20identifies%20gene%20expression%20networks%20driving%20differentiation%20and%20tumorigenesis%20in%20the%20human%20fallopian%20tube.%20Cell%20Rep.%202021;35(2):108978." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366147/bin/13048_2025_1766_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (156KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Ovarian Research are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13048-025-01766-4"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13048_2025_Article_1766.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366147/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366147/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366147%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366147/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366147/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366147/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40835947/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366147/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40835947/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366147/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366147/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="d07OLVDEKBbTfDZBysnrp7D5gTP27MEnWifTN2dnPGAFxf1iP8xRERHaa33ono5F">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
